📰 Mark Levick News
Page 2 - Mark Levick News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mark Levick. Real-time updates on events, politics, business and more.
February 28, 2022
Alvotech is the only known company to have both developed a high-concentration biosimilar to Humira and conducted a switching study to support…
February 3, 2022
Alvotech and BiosanaPharma have signed an exclusive global licensing agreement for the co-development of a proposed biosimilar, AVT23 (also called BP001)
February 2, 2022
Alvotech Holdings S.A. ("Alvotech"), a global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients worldwide, has entered into an exclusive
January 18, 2022
Alvotech Holdings S.A. ("Alvotech"), a leading global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients worldwide, and Oaktree Acquisition
December 15, 2021
Alvotech Holdings S.A. ("Alvotech"), a global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients worldwide, received approval for AVT02 (100
December 15, 2021
Press release content from Business Wire. The AP news staff was not involved in its creation.
December 8, 2021
Alvotech has signed a definitive merger agreement with Oaktree Acquisition Corp II to form a publicly-traded biopharmaceutical company.
December 7, 2021
Alvotech is a leading pure play biosimilar platform focused on the development and manufacture of high-quality biosimilar medicines for global markets. Biosimilars are therapeutic equivalents to